Press Releases

Introduction of Drug-Eluting Stents Addresses Concerns with Current Stents, According to Millennium Research Group

Declining Demand in Private Practices for Diagnostic ECG Devices will Contribute to the Slow Growth, According to Millennium Research Group

Drug-Eluting Stents and Innovations in Bioabsorbable Stents Will Maintain Premium Prices and Help Support the Market, According to Millennium Research Group

Despite Downward Pressure on Average Selling Prices, Procedural Growth Will Drive Revenues, According to Millennium Research Group

Growth is Attributed to the Rising Volume of Procedures, According to Millennium Research Group

Strongest Growth to be in the Direct Energy and Single-Port Device Segments, According to Millennium Research Group

Lower Procedure Volumes and Continued Price Erosion the Cause,  According to Millennium Research Group

Hyaluronic Acid (HA) Viscosupplementation Market to Show Strongest Growth, According to Millennium Research Group

Market Supported by Strong Growth in Brazil, India and China, as Well as the Increased Adoption of Premium-Priced Devices, According to Millennium Research Group

Millennium Research Group’s New Physician Forum Report Provides Details of Physician Attitudes and Choices